Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: A Cardiac Safety Study.
Phase of Trial: Phase III
Latest Information Update: 15 Jan 2010
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 21 Nov 2006 New trial record.